• PIMECROLIMUS chembl:CHEMBL1200686 ApprovedImmunotherapy

    Alternate Names:

    SDZ-ASM 981
    PIMECROLIMUS
    SDZ-ASM-981
    ELIDEL
    SDZ ASM 981
    SDZ ASM-981
    ASM981
    PIMECROLIMUSUM
    ELIDEL®
    33-EPI-CHLORO-33-DESOXYASCOMYCIN
    chemidplus:137071-32-0
    pubchem.compound:6509979
    chembl:CHEMBL1200686
    rxcui:321952
    drugbank:00337

    Drug Info:

    Drug Class anti-inflammatory agents, non-steroidal
    Year of Approval 2001
    FDA Approval approved
    Drug Class Small Molecule
    Drug Indications antiinflammatory agent
    (1 More Sources)
  • Interaction Score: 5.32

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    TTD

  • Interaction Score: 4.56

    Interaction Types & Directionality:
    inhibitor (inhibitory)
    potentiator

    Interaction Info:
    Direct Interaction yes
    Mechanism of Interaction FK506-binding protein 1A inhibitor

    PMIDs:
    12113647


  • Interaction Score: 0.32

    Interaction Types & Directionality:
    potentiator

    Interaction Info:
    Trial Name pimecrolimus, ASM 981,Elidel
    Novel drug target Established target

    PMIDs:
    12113647


    Sources:
    TdgClinicalTrial

    • Version: 01-August-2011

    Alternate Names:
    PIMECROLIMUS Primary Drug Name

    Drug Info:
    Year of Approval 2001
    Drug Class anti-inflammatory agents, non-steroidal

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antiinflammatory agent
    Drug Class Small Molecule
    FDA Approval approved

    Publications:

    • Version: 2020.06.01

    Alternate Names:
    D0Z4UN TTD Drug ID

    Drug Info:

    Publications:

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications: